Literature DB >> 12374764

Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in platelets.

Kathleen Freson1, Chantal Thys, Christine Wittevrongel, Willem Proesmans, Marc F Hoylaerts, Jos Vermylen, Chris Van Geet.   

Abstract

Pseudohypoparathyroidism Ib (PHPIb), characterized by parathyroid hormone-resistant hypocalcemia and hyperphosphatemia, is caused by a deregulation in the imprinting status of the GNAS1 cluster, comprising exons XL, NESP55 and 1A and the coding exons of Gsalpha. Differences in methylation of exon 1A and sporadically also of exons XL and NESP55 were found and thought to result in long-range effects on Gsalpha expression, limited to the proximal renal tubules. The exact imprinting defect is not precisely localized, and the expected differences in Gsalpha protein level and function are mainly hypothetical. We describe a PHPIb patient with lack of methylation of the exon XL and 1A promoters, and biallelic methylation of the NESP55 promoter. Platelets of this patient show a functional Gs defect, decreased cAMP formation upon Gs-receptor stimulation, normal Gsalpha sequence but reduced Gsalpha protein levels. Transcriptional deregulation between the now biallelically active promoters of both exon 1A and exon 1 of Gsalpha could explain the decreased Gsalpha expression in platelets and presumably in the proximal renal tubules. We found decreased NESP55 and increased XLalphas protein levels in platelets, in agreement with the methylation status of their corresponding first exons. In a megakaryocytic cell line MEG-01, exon 1A is methylated on both alleles, in contrast to the normally maternally methylated exon 1A in leukocytes. Experimental demethylation of exon 1A in MEG-01 cells led to reduced Gsalpha expression, in agreement with the observations in the patient. Platelet studies may therefore allow easy evaluation of disturbances of the GNAS1 cluster in PHPIb patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374764     DOI: 10.1093/hmg/11.22.2741

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  6 in total

1.  Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1.

Authors:  Suzanne Jan de Beur; Changlin Ding; Emily Germain-Lee; Justin Cho; Alexander Maret; Michael A Levine
Journal:  Am J Hum Genet       Date:  2003-07-11       Impact factor: 11.025

2.  Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.

Authors:  John D Phillips; David P Steensma; Michael A Pulsipher; Gerald J Spangrude; James P Kushner
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

3.  Interplay between polymorphisms and methylation in the H19/IGF2 gene region may contribute to obesity in Mexican-American children.

Authors:  M A Hernández-Valero; J Rother; I Gorlov; M Frazier; O Gorlova
Journal:  J Dev Orig Health Dis       Date:  2013-12       Impact factor: 2.401

Review 4.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

5.  Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunction.

Authors:  Benedetta Izzi; Inge Francois; Veerle Labarque; Chantal Thys; Christine Wittevrongel; Koen Devriendt; Eric Legius; Annick Van den Bruel; Marc D'Hooghe; Diether Lambrechts; Francis de Zegher; Chris Van Geet; Kathleen Freson
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

6.  Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions.

Authors:  Nupur Raychaudhuri; Roshini Fernando; Terry J Smith
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.